• NEBANNER

4-[4-[(5S) -5-(Aminomethyl) -2-oxo-3-oxazolidinyl] phenyl] -3-morpholinone Hydrochloride

4-[4-[(5S) -5-(Aminomethyl) -2-oxo-3-oxazolidinyl] phenyl] -3-morpholinone Hydrochloride

Takaitaccen Bayani:

Tsarin kwayoyin halitta: C14H17N3O4·HCl

Nauyin kwayoyin halitta:327.77

CAS BA:898543-06-1


Cikakken Bayani

Tags samfurin

Aikace-aikace

12.Matsakaicin 4- (4-aminophenyl) -3-morpholinone (1) na anticoagulant rivaroxaban an shirya shi ta hanyoyi guda biyu: ①Bromobenzene an yi nasara tare da ethanolamine da chloroacetyl chloride don samun 4-benzene. 1, kuma jimlar yawan amfanin ƙasa shine kusan 32%;②An fara nitrated Bromobenzene, sannan a mayar da martani da ethanolamine don samun 2- (4-nitroanilino) ethanol, wanda chloroacetyl chloride ya rufe.Sakamakon raguwa yana haifar da 1, kuma jimlar yawan amfanin ƙasa shine kusan 47%.

Rivaroxaban wani sabon nau'in maganin ciwon zuciya ne wanda za'a iya sha kai tsaye ta baki.Yana hana kai tsaye da kunna coagulation factor Xa, yana da tabbataccen sakamako na anticoagulant, baya buƙatar ci gaba da saka idanu, kuma yana da babban aminci.Tare da aikace-aikacen asibiti na rivaroxaban, Buƙatar rivaroxaban zai ƙaru a hankali.Sunan sinadarai na rivaroxaban shine 5-chloro-N-(((5S) -2-oxo-3-[4- (3-oxo- 4-morpholinyl) phenyl)) -1,3-oxazolidine-5-yl) methyl -2-thiophenecarboxamide.A halin yanzu akwai hanyoyi guda biyu na synthetic da aka ruwaito a cikin wallafe-wallafen, kuma ana amfani da hanyoyi guda biyu A matsakaici 4- (4-aminophenyl) -3-morpholinone.Ko da yake akwai rahotanni game da kira na 4- (4-aminophenyl) -3-morpholinone a gida da waje, akwai farashi mai mahimmanci na kayan aiki.Maɗaukaki, da wuyar siye, ko buƙatun aiki na amsawa sun yi yawa, da wuya a fahimta, ba su dace da kariyar muhalli da sauran ƙarancin ba, kuma ba su cika buƙatun samar da masana'antu ba.Inganta maɓalli mai mahimmanci na rivaroxaban 4- (4-aminophenyl) - Tsarin samar da 3-morpholinone da rage farashin albarkatun kasa tabbas zai inganta haɓakawa da aikace-aikacen rivaroxaban.Babu wani rahoto kan hada-hadar rivaroxaban a kasar Sin.Muna a rivaroxaban Maɓallin tsaka-tsakin 4-- (4-aminophenyl) -3-morpholinone synthetic hanya da fasaha an yi nazarin sabbin abubuwa.Biyu bromobenzene da p-nitrobromobenzene kamar yadda aka gabatar da kayan farawa.Hanyar hanya.Mayar da hankali kan tsarin hawan keke na zoben 3-morpholinone.

Matsayin gudanarwa:ma'aunin kasuwanci
Na waje:Farin crystalline foda

Kunshin:25kg/drum
assay (HPLC) Abun ciki mafi girma ko daidai da 98.0%

Layin Samfuri mai haɗaka da albarkatu

wps_doc_0

Takaddun shaida

JIN DUN Medical yaCancantar ISO kuma ya cika ka'idodin samar da GMP, ƙwararrun ƙwararrun haɗaɗɗun ƙwayoyi na cikin gida da na waje tare da ƙwararrun ƙwarewa don jagorantar R&D na kamfani.

13
d68590fe
12
111

Abũbuwan amfãni a kan Gyaran Likita

TECHNOL OGY AMFANIN
●High Matsi Catalytic Hydrogenation.Babban Matsi na Hydrogenolysis Reaction.Maganin Cryogenic (<-78% C)
●Aromatic Heterocyclic Synthesis
●Maganar Sake Shiryawa
●Matsalar Chiral
●Heck, Suzuki,Negishi,Sonogashira .Gignard Reaction

JIN DUN R&D

Kayan aiki

Our Lab yana da daban-daban na gwaji da kuma gwaji kayan aiki, kamar: NMR (Bruker 400M), HPC, Chiral-HPLC, LC-MS, LC-MS/MS (API 4000) , IR, UV, GC, GC-MS, Chromatography, Microwave Synthesizer, Parallel Synthesizer, Bambance-bambancen Scanning Calorimeter (DSC), Electron Microscope...

Ƙungiyar R&D

Jindun Medical yana da rukuni na ƙwararrun ma'aikatan R&D, kuma yana ɗaukar ƙwararrun masana harhada magunguna na cikin gida da na waje don jagorantar R&D, yana sa ƙirarmu ta fi dacewa da inganci.

wps_doc_3

Raba Harka

Mun taimaka wa manyan kamfanonin harhada magunguna na cikin gida da yawa, kamarHansoh, Hengrui da HEC Pharm.Anan zamu nuna sashinsu.

wps_doc_4

Hali na Farko na Farko:

Lambar Waya: 110351-94-5

wps_doc_5

Hali na Musamman na Biyu:

Lambar Waya: 144848-24-8

wps_doc_6

Halin Hali na Uku:

Lambar Waya: 200636-54-0

Yanayin Haɗin kai

1.Keɓance Sabbin Matsakaici ko APIs.Daidai da raba shari'ar na sama, abokan ciniki suna da buƙatun takamaiman Matsakaici ko APIs, kuma ba za su iya samun samfuran da ake buƙata ba a kasuwa, sannan za mu iya taimakawa don Keɓancewa.

2.Haɓaka Tsari don Tsofaffin Kayayyaki.Ƙungiyarmu za ta taimaka don ingantawa da haɓaka irin wannan samarwa wanda hanyar amsawa ta tsufa, farashin samarwa yana da yawa, kuma ingancin ya yi ƙasa.Za mu iya samar da cikakkun takardun shaida don canja wurin fasaha da haɓaka tsari, taimakawa abokin ciniki don samar da ingantaccen aiki.

Daga maƙasudin miyagun ƙwayoyi zuwa INDs, JIN DUN Medical yana ba kumafita na R&D keɓaɓɓen tsayawa ɗaya tasha.

JIN DUN Medical ya dage kan ƙirƙirar ƙungiyar tare da mafarkai, yin samfura masu daraja, ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwaƙƙwaran, masu tsattsauran ra'ayoyi, masu tsauri, da kuma fita gabaɗaya don zama amintaccen abokin tarayya kuma abokin abokan ciniki!


  • Na baya:
  • Na gaba:

  • Ku rubuta sakonku anan ku aiko mana